Crossmark

Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma

Crossref DOI link: https://doi.org/10.1186/s40880-019-0398-0

Published Online: 2019-10-25

Published Print: 2019-12

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Liu, Li‐Ting

Chua, Melvin L. K.

Tao, Yungan

Tang, Lin‐Quan

Mai, Hai‐Qiang
Funding

Funding for this research was provided by:

National Basic Research Program of China (2017YFC0908500, 2017YFC1309003)

National Natural Science Foundation of China (81425018, 81672868, 81602371)

AstraZeneca

Varian Medical Systems

Sanofi
License Information

Version of Record valid from 2019-10-25
More Information

Publication History

Received: 2019-09-20

Accepted: 2019-09-23

Published: 2019-10-25

Document is current

Any future updates will be listed below